The conversation around equity in care continues as our co-hosts interview Nasrien Ibrahim, MD, the founder and executive director of the nonprofit The Equity in Heart Transplant Project, Inc. about creative solutions for helping historically excluded and systemically oppressed patients become better candidates for transplant and other advanced heart failure therapies. On From Failure to Function Priya discusses the ALT FLOW trial presented at THT 2023 that looks at using left atrial to coronary sinus shunting to treat symptomatic heart failure; and on HF Rounds Michael reviews a new scientific statement on Natriuretic Peptides from HFSA, JHFS, and ESC-HFA.